Commentary
The Role of Immunosuppression in Gene- and Cell-Based Treatments for Duchenne Muscular Dystrophy
Valder R Arruda1
1Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Correspondence: Valder R Arruda, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 3615 Civic Center Blvd., Philadelphia, Pennsylvania 19107, USA. E-mail: arruda@email.chop.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Utrophin to the rescueNature News and Views (28 Nov 1996)
Utrophin muscles in on the actionNature Medicine News and Views (01 Jan 1997)
NO vascular control in Duchenne muscular dystrophyNature Medicine News and Views (01 Jan 2001)
Stem-cell biology A move in the right directionNature News and Views (30 Nov 2006)
Sizing up muscular dystrophyNature Medicine News and Views (01 Dec 2002)
See all 6 matches for News And Views